Elysium’s antiaging product is Basis, which can ordered online without a prescription. It costs $50 for a month’s supply. Basis is designed to optimize NAD+ levels and sirtuin function in our cells to ...
An anti-aging startup hopes to elude the U.S. Food and Drug Administration and death at the same time. The company, Elysium Health, says it will be turning chemicals that lengthen the lives of mice ...
Is 50 the new 30? Or is 30 the new 50? A New York City–based biotech company, Elysium Health, believes it can help you figure that out with unprecedented levels of accuracy using a simple, though ...
Spoiler alert: The health of your cells declines as you age, which could affect your overall wellbeing as each birthday rolls around. But for those of us who never think about our bodies down to this ...
Let's face it: Most supplements are a little bit sketchy. It's not just that many of them don't actually contain what they say they do — the science on their alleged benefits is also mixed at best.
I’m only 33 now, and I can already feel myself getting older. My shoulder has been hurting me for a few weeks, I can’t sit for as long as I used to without getting a bit of pain in my lower back and I ...
“My driver’s license says I’m [so] many years old, that’s how many trips around the sun I’ve taken,” says Elysium Health CEO Eric Marcotulli. But, he wonders aloud, “is that an accurate representation ...
Developed with the advisement of Michael Fredericson, M.D., Co-Director of the Stanford Center on Longevity, Creatine+ uniquely combines creatine monohydrate with HMB and pomegranate polyphenols NEW ...
A startup that's developing an anti-aging supplement just raised $20 million to keep studying it and other supplements. Elysium Health, the brainchild of former Sequoia partner Eric Marcotulli, former ...
LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (NASDAQ:CDXC) issued the following statement: Given recently announced court closures and other restrictions due to the COVID-19 pandemic, the company ...
LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC) issued the following statement: Given recently announced court closures and other restrictions due to the COVID-19 pandemic, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results